Health Condition 1: null- Under eye dark circles (Infra orbital hyperchromia)
Conditions
Interventions
Intervention1: Wunder eye cream (3% Biophytex LS 8740 and 5% Proteasyl TP LS 8657): one FTU (Finger Tip Unit) to be applied twice daily in the affected under eye dark circle area for 8 weeks
Control I
Sponsors
Glenmark Pharmaceutical limited
Eligibility
Inclusion criteria
Inclusion criteria: Subjects eligible for enrolment in the study must meet all the following criteria. Subjects with mild, moderate or severe under eye dark circles Subjects must be 18-50 years of age Subjects must provide written informed consent and comply to the protocol
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criteria must not be enrolled in the clinical study. Subjects not willing to discontinue all topical treatments for ?Under Eye? dark circles for 2 weeks prior to enrollment in study Hypersensitivity to any ingredients of Wunder Eye cream Pregnant and lactating women Subjects taking Concomitant therapy* that might interfere with the study results Subjects with dermatological disorder of face that may interfere with study evaluation Subjects who have undergone any surgical treatment of the face *Concomitant topical therapy in under eye area that causes hypopigmentation, includes Retinoids and Hyroquinone skin peels. *Concomitant medicines, that causes hyper pigmentation, includes Phenothiazines, Anti-malarials (Chloroquine), Phenytoin sodium, Cytotoxic drugs, Sulphonamides.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment for Efficacy includes the following: Area of under eye pigmentation ? Improvement in luminance of under eye skin ? Reduction in Under eye puffiness and ? Reduction in Under eye wrinkles Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Rajesh Lalchandani
Outcome results
None listed